Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00219947 · ClinicalTrials.gov registry record
Viral and Host Factors in the Transmission and Pathogenesis of HIV
A clinical trial, sponsored by Rockefeller University.
- Terminated
- Registry status
- 600
- Enrollment target
NCT00219947 is a clinical trial that was terminated before completion, run by Rockefeller University. The registered enrollment target is 600 participants.
The verdict
NCT00219947 was terminated before completion, sponsored by Rockefeller University.
- TERMINATED
- Registry status
- 600 participants
- Enrollment target
Study Summary
To study the collection of blood from individuals known to be at high risk for HIV-infection or who have been recently infected with HIV. The data collected are used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment Guidelines.
Interventions
- OTHER blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2000-07 |
| Est. Completion | 2019-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00219947
The ClinicalTrials.gov registry entry for NCT00219947 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood draw is the first listed.
NCT00219947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00219947 about?
NCT00219947 is a clinical study titled "Viral and Host Factors in the Transmission and Pathogenesis of HIV". To study the collection of blood from individuals known to be at high risk for HIV-infection or who have been recently infected with HIV. The data collected are used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment Guidelines.
What is the current status of trial NCT00219947?
This trial is currently terminated. The enrollment target is 600 participants. The study started on 2000-07. Estimated completion is 2019-03.
What interventions are being tested in trial NCT00219947?
The interventions under investigation include: blood draw (OTHER).
Who is sponsoring clinical trial NCT00219947?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.